April 22, 2024

Global Innovation Summit 2026

Global Innovation Summit 2026

Welcome to the Global Innovation Summit!

The Global Innovation Summit 2026 is your opportunity to kick off your innovation project with international partners, strengthen your business and explore suitable funding opportunities in over 40 countries.

The one-day event will take place on Wednesday, 6 May 2026 at Messe Basel, Switzerland.

Why attend the Global Innovation Summit 2026?

The Global Innovation Summit is a recurring gathering organised in the framework of Eureka the world’s largest network for supporting collaborative innovation.

The 2026 edition is organised by the Swiss Eureka Chair represented by Innosuisse and focuses on innovation in the biotech industry combined with enabling technologies and services like digitalisation, translational research and development, chemistry, manufacturing, control and quality control processes, etc.

It will feature an international public, inspiring keynotes and a strong focus on matchmaking for international projects. With a thousand participants expected, the Summit offers a unique chance to turn your ideas into action on a global scale.

The Global Innovation Summit runs back-to-back with the annual Swiss Biotech Day and aims at linking the Swiss biotech ecosystem with global businesses and science to strengthen international cooperation.

  • 🌍 Explore international collaboration.
  • 🤝 Make meaningful connections for project funding.
  • 🎤 Learn from industry leaders.
  • 💡 Get inspired.
  • 🚀 Stay ahead of the curve.
  • 🎉 Enjoy the experience.
  • ✨ Attend free of charge.

Take the opportunity to connect, exchange ideas and collaborate. Register now!

register now

Our latest News

discover more
RHEACELL makes second location in Heidelberg visible

RHEACELL makes second location in Heidelberg visible

Heidelberg, January 28, 2026 – RHEACELL GmbH & Co. KG is continuing to expand its presence in Heidelberg and moved into a second location in the Pfaffengrund district in August last year. At the start of the year, the location is now also becoming visible to the outside world: this week, the company logo will […]

TUM Researchers receive two ERC Grants

TUM Researchers receive two ERC Grants

The European Research Council’s (ERC) Proof of Concept Grants are designed to help researchers turn their findings into real‑world innovations. Two ERC‑funded follow‑up projects at TUM will each receive approximately 150,000 euros in support. The projects focus on virus‑driven cancer treatments and new ways to supply electrons for enzyme‑based technologies. Researchers at TUM have secured […]

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Cachexia is a metabolic disorder that causes uncontrolled weight loss and muscle wasting in chronic diseases and cancer. A new study by Helmholtz Munich, in collaboration with the Institute of Physiology of the Czech Academy of Sciences in Prague, Heidelberg University Hospital, the German Center for Diabetes Research (DZD), and the German Center for Cardiovascular […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp